30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
On August 29, 2019, the National Labor Relations Board (“NLRB”) held that misclassifying an employ...
Read More >
As its session draws to a close, the New York State Legislature substantially revised the state’s a...
Read More >
The Federal Trade Commission (FTC) has revised the thresholds that govern pre-merger notification re...
Read More >
An Oklahoma refinery employee who was terminated after testing positive for amphetamines tried to ge...
Read More >
Final Overtime Rule Advances. The U.S. Department of Labor’s Wage and Hour Division’s proposal to ...
Read More >
Arizona’s minimum wage is set to increase to $12.00 on January 1, 2020. The $1.00 increase is the ...
Read More >